There is often confusion between doing the right things and doing things right. Perhaps the best way to explain the difference is with an example.
There is often confusion between doing the right things and doing things right. Perhaps the best way to explain the difference is with an example.
While I was on a trip to Japan, my secretary decided to completely reorganize a file cabinet that had been neglected for quite some time. On my return, she informed me that she had done an excellent job in bringing the file cabinet up to date. She actually did an outstanding job - an example of doing the right thing. Unfortunately, almost all the material in that particular cabinet should have been thrown out long ago.
Of course, we are going to use a strategic thinking tool for the analysis of this subject. In the 2 x 2 shown in the figure (for details on this tool, see DI SCAN 8/9/06 Successful technology implementation makes medical imaging tick), we have broken the challenge of analysis into four possibilities. Usually in a 2 x 2, one of the boxes can be rapidly eliminated from discussion because of its lack of value. This is certainly the case for the box in the lower left corner, the doing the wrong thing and doing things wrong box.
Let's focus next on the upper left box, characterized by doing the right thing and doing things wrong. A good example of this is the attempted launch of CT by EMI. EMI was the creator of the concept and did an outstanding job in getting the first useful anatomic pictures. Some historians claim that all major manufacturers in the x-ray business turned down an EMI offer to partner on the CT project. So EMI went it alone, despite having no prior experience in the imaging business. One of the key reasons for the company's downfall was that it didn't understand service and the need to please the customer with the uptime of the imaging device. Because initial orders came from many locations around the world, EMI was not able to benefit from the "cluster concept" and, therefore, was unable to provide consistent and excellent service.Our next area of consideration is the lower right box, characterized by doing the wrong thing and doing things right. This is clearly a wasteful endeavor in that good energy and resources are being used in an area that won't repay their expenditure. That certainly was the situation when lithotripsy companies, after their success treating kidneys, decided to expand to the gall bladder. But this decision backfired due to a lack of understanding about the competition. Thinking of competition as other lithotripsy companies, they did not consider competing technologies. These included pharmaceuticals capable of dissolving gall stones, which is not possible with kidney stones, and surgery, as the gall bladder is not required for patient survival. The availability of laparoscopy allowed minimally invasive surgical techniques to be used, making surgery an even more attractive option.This brings us to the upper right box - the desired place to be - doing the right things and doing things right. The examples included are just a few of the many that are available. Are there some underlying characteristics associated with the cases shown? The answer has been provided in a number of the articles in DI SCAN. The High 5 (DI SCAN, 4/7/06, High 5 highlights importance of understanding the competition) shows the importance of understanding the customer and having a balanced approach to serving customers' needs, including excellent technology and a focus on service and support. Total Service (DI SCAN, 9/1/06, The future of total service ranks a 'high five') further amplified on the various aspects of service and support and how this has changed over time. New Technology Adoption (DI SCAN, 8/1/06, Successful technology implementation makes medical imaging tick) demonstrated the importance of the need for the customer to change behavior when incorporating new technology in order to achieve long-lasting success. In addition, all of the examples in the upper right box show an excellent understanding of competition and what is required for attaining and maintaining a leadership position.Ronald Schilling, Ph.D., is an editorial advisor to Diagnostic Imaging and president of RBS Consulting in Los Altos Hills, CA. Comments can be addressed to ronald11341@aol.com.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.